Trexquant Investment’s Olema Pharmaceuticals OLMA Stock Holding History

Trexquant Investment’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Sell	92,412 -232,761	-72%	-$3.12M	0.01%	1412
2026 Q1	$4.85M	Buy	325,173 +275,419	+554%	+$6.13M	0.03%	660
2025 Q4	$1.24M	Buy	+49,754	New	+$885K	0.01%	1115
2024 Q4	–	Sell	-120,093	Closed	-$1.43M	–	1774
2024 Q3	$1.43M	Buy	120,093 +5,451	+5%	+$69.7K	0.02%	923
2024 Q2	$1.24M	Buy	+114,642	New	+$1.24M	0.02%	930
2023 Q4	–	Sell	-11,151	Closed	-$138K	–	1681
2023 Q3	$138K	Buy	+11,151	New	+$114K	﹤0.01%	1378
2021 Q3	–	Sell	-12,335	Closed	-$345K	–	1385
2021 Q2	$345K	Buy	+12,335	New	+$351K	0.03%	645

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Trexquant Investment's OLMA Position: Q2 2026 in Review

Trexquant Investment reduced its Olema Pharmaceuticals (OLMA) stake by 72% in Q2 2026, selling an estimated $3.12M and leaving 92,412 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #1412.

Trexquant Investment first reported a position in OLMA in Q2 2021 and has held it in 7 quarters since. The position peaked at $4.85M in Q1 2026. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Trexquant Investment held 92,412 shares of Olema Pharmaceuticals worth $1.16M as of Q2 2026.
Trexquant Investment sold 232,761 Olema Pharmaceuticals shares in Q2 2026, an estimated $3.12M.
Olema Pharmaceuticals made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1412 holding.
Trexquant Investment first reported a position in Olema Pharmaceuticals in Q2 2021 and has held it in 7 quarters since.
Trexquant Investment's Olema Pharmaceuticals position peaked at $4.85M in Q1 2026.
186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.